Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer

被引:21
|
作者
Inamori, Koji [1 ,2 ,3 ,4 ,5 ]
Togashi, Yosuke [1 ]
Fukuoka, Shota [1 ]
Akagi, Kiwamu [6 ]
Ogasawara, Kouetsu [7 ]
Irie, Takuma [1 ]
Motooka, Daisuke [8 ]
Kobayashi, Yoichi [9 ,10 ]
Sugiyama, Daisuke [9 ]
Kojima, Motohiro [11 ]
Shiiya, Norihiko [3 ,4 ,5 ]
Nakamura, Shota [8 ]
Maruyama, Shoichi [10 ]
Suzuki, Yutaka [12 ]
Ito, Masaaki [2 ]
Nishikawa, Hiroyoshi [1 ,9 ]
机构
[1] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr EPOC, Div Canc Immunol, Res Inst, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan
[2] Natl Canc Ctr Hosp East NCCHE, Dept Colorectal Surg, Chiba, Japan
[3] Hamamatsu Univ, Div Cardiovasc, Surg 1, Sch Med, Hamamatsu, Shizuoka, Japan
[4] Hamamatsu Univ, Div Thorac, Surg 1, Sch Med, Hamamatsu, Shizuoka, Japan
[5] Hamamatsu Univ, Div Gen Endoscop & Breast Surg, Surg 1, Sch Med, Hamamatsu, Shizuoka, Japan
[6] Saitama Canc Ctr SCC, Div Mol Diag & Canc Prevent, Saitama, Japan
[7] Tohoku Univ, Inst Dev Aging & Canc, Dept Immunobiol, Sendai, Miyagi, Japan
[8] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan
[9] Nagoya Univ, Grad Sch Med, Dept Immunol, Nagoya, Aichi, Japan
[10] Nagoya Univ, Dept Nephrol, Grad Sch Med, Nagoya, Aichi, Japan
[11] NCCHE, Div Pathol, Chiba, Japan
[12] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba, Japan
关键词
REGULATORY T-CELLS; MICROSATELLITE INSTABILITY; PD-1; BLOCKADE; CLINICOPATHOLOGICAL FEATURES; EXPRESSION; TUMORS; COLON; INFILTRATION; MULTICENTER; IMMUNOLOGY;
D O I
10.1172/jci.insight.137365
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Patients with colorectal cancers (CRCs) generally exhibit improved survival through intensive lymph node (LN) dissection. However, recent progress in cancer immunotherapy revisits the potential importance of regional LNs, where T cells are primed to attack tumor cells. To elucidate the role of regional LN, we investigated the immunological status of nonmetastatic regional LN lymphocytes (LNLs) in comparison with those of the tumor microenvironment (tumor-infiltrating lymphocytes; TILs) using flow cytometry and next-generation sequencing. LNLs comprised an intermediate level of the effector T cell population between peripheral blood lymphocytes (PBLs) and TILs. Significant overlap of the T cell receptor (TCR) repertoire was observed in microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) CRCs with high tumor mutation burden (TMB), although limited TCRs were shared between nonmetastatic LNs and primary tumors in microsatellite stable/MMR proficient (MSS/pMMR) CRC patients with low TMB. In line with the overlap of the TCR repertoire, an excessive LN dissection did not provide a positive impact on long-term prognosis in our MSI-H/dMMR CRC cohort (n = 130). We propose that regional LNs play an important role in antitumor immunity, particularly in MSI-H/dMMR CRCs with high TMB, requiring care to be taken regarding excessive nonmetastatic LN dissection in MSI-H/dMMR CRC patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Opportunities and challenges of immunotherapy for dMMR/MSI-H colorectal cancer
    Qi Zhang
    Jian Li
    Lin Shen
    Yongsheng Li
    Xicheng Wang
    Cancer Biology & Medicine, 2023, 20 (10) : 706 - 712
  • [2] Immunotherapy Promising for Metastatic MSI-H/dMMR Colorectal Cancer
    Yarden, Ronit
    ONCOLOGY-NEW YORK, 2019, 33 (05): : 179 - 179
  • [3] Opportunities and challenges of immunotherapy for dMMR/MSI-H colorectal cancer
    Qi Zhang
    Jian Li
    Lin Shen
    Yongsheng Li
    Xicheng Wang
    Cancer Biology & Medicine, 2023, (10) : 706 - 712
  • [4] Opportunities and challenges of immunotherapy for dMMR/ MSI-H colorectal cancer
    Zhang, Qi
    Li, Jian
    Shen, Lin
    Li, Yongsheng
    Wang, Xicheng
    CANCER BIOLOGY & MEDICINE, 2023, 20 (10) : 706 - 712
  • [5] Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients
    Margalit, Ofer
    Stemmer, Amos
    Chapin, William J.
    Shacham-Shmueli, Einat
    Kopetz, Scott
    Andre, Thierry
    Overman, Michael J.
    Pietrantonio, Filippo
    Boursi, Ben
    EUROPEAN JOURNAL OF CANCER, 2024, 212
  • [6] Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape
    Mulet-Margalef, Nuria
    Linares, Jenniffer
    Badia-Ramentol, Jordi
    Jimeno, Mireya
    Monte, Carolina Sanz
    Mozo, Jose Luis Manzano
    Calon, Alexandre
    CANCERS, 2023, 15 (04)
  • [8] Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H/dMMR colorectal cancer
    Yupeng Jiang
    Yuyao Liu
    Hong Huang
    Tiantian Zhao
    Zengyi Zhao
    Yawen Gao
    Cancer Immunology, Immunotherapy, 74 (3)
  • [9] PD-1 inhibition in metastatic dMMR/MSI-H colorectal cancer
    Sclafani, Francesco
    LANCET ONCOLOGY, 2017, 18 (09): : 1141 - 1142
  • [10] Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers
    Fuca, Giovanni
    Cohen, Romain
    Lonardi, Sara
    Shitara, Kohei
    Elena Elez, Maria
    Fakih, Marwan
    Chao, Joseph
    Klempner, Samuel J.
    Emmett, Matthew
    Jayachandran, Priya
    Bergamo, Francesca
    Diez Garcia, Marc
    Mazzoli, Giacomo
    Provenzano, Leonardo
    Colle, Raphael
    Svrcek, Magali
    Ambrosini, Margherita
    Randon, Giovanni
    Shah, Aakash Tushar
    Salati, Massimiliano
    Fenocchio, Elisabetta
    Salvatore, Lisa
    Chida, Keigo
    Kawazoe, Akihito
    Conca, Veronica
    Curigliano, Giuseppe
    Corti, Francesca
    Cremolini, Chiara
    Overman, Michael
    Andre, Thierry
    Pietrantonio, Filippo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (02)